| Income Statement |
| Total Revenue | 90.48M |
|
| Revenues (USD) | 90.48M |
| Cost of Revenue | 9.96M |
| Gross Profit | 80.52M |
| Operating Expenses | 65.97M |
| Research and Development Expense | 33.72M |
| Selling, General and Administrative Expense | 28.14M |
| Operating Income | 14.55M |
| Interest Expense | 252.00K |
| Income Tax Expense | 4.60M |
| Net Income | 12.83M |
| Net Income Common Stock | 12.83M |
| Net Income Common Stock (USD) | 12.83M |
| Consolidated Income | 12.83M |
| Earnings per Basic Share | 0.08 |
| Earnings per Basic Share (USD) | 0.08 |
| Earnings per Diluted Share | 0.07 |
| Earning Before Interest & Taxes (EBIT) | 17.68M |
| Earning Before Interest & Taxes (USD) | 17.68M |
| Weighted Average Shares | 151.72M |
| Weighted Average Shares Diluted | 175.50M |
| Balance Sheet |
| Cash and Equivalents | 442.04M |
| Cash and Equivalents (USD) | 442.04M |
| Investments | 689.01M |
| Investments Current | 689.01M |
| Trade and Non-Trade Receivables | 303.42M |
| Current Assets | 1.49B |
| Property, Plant & Equipment Net | 15.14M |
| Total Assets | 1.62B |
| Debt Current | 4.16M |
| Total Debt | 9.39M |
| Current Liabilities | 998.88M |
| Debt Non-Current | 5.23M |
| Total Liabilities | 1.01B |
| Accumulated Retained Earnings (Deficit) | -129.17M |
| Shareholders Equity | 614.19M |
| Shareholders Equity (USD) | 614.19M |
| Assets Non-Current | 134.66M |
| Total Debt (USD) | 9.39M |
| Liabilities Non-Current | 7.19M |
| Trade and Non-Trade Payables | 292.82M |
| Tax Assets | 115.87M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.30M |
| Net Cash Flow from Financing | -30.84M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.14M |
| Capital Expenditure | -985.00K |
| Issuance (Purchase) of Equity Shares | -26.18M |
| Net Cash Flow from Investing | -985.00K |
| Net Cash Flow from Operations | 22.68M |
| Share Based Compensation | 17.05M |